About

Publications While At HealthPartners

selected publications

Journal Article

Consistent findings in glycaemic control, body weight and hypoglycaemia with iGlarLixi (insulin glargine/lixisenatide titratable fixed-ratio combination) vs insulin glargine across baseline HbA1c, BMI and diabetes duration categories in the LixiLan-L trial. 

Diabetes, Obesity & Metabolism. 2017

Abstract

Efficacy and safety of LixiLan vs. insulin glargine according to baseline characteristics in patients with type 2 diabetes from the LixiLan-L Trial [abstract 1018-P]. 

Diabetes. 2016

Contact

full name

R. C. Bonadonna

Quick Info

 

Collaboration

Co-author network

Map of science